Ginkgo Bioworks insider plans sale of 2,200 Class A shares

Ginkgo Bioworks insider plans another small Class A share sale.

Rhea-AI Filing Summary

Ginkgo Bioworks insider plans another small Class A share sale. A holder has filed a notice to sell 2,200 shares of Class A common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $20,988.00. The filing lists 48,523,595 Class A shares outstanding.

The seller, identified as Austin Che, acquired these shares through restricted stock vesting in October 2022 as compensation from the issuer. Over the past three months, the same seller reported three separate NYSE sales of 2,200 Class A shares each, with gross proceeds of $23,716.00, $33,462.00, and $18,700.00. The notice also includes a representation that the seller is not aware of undisclosed material adverse information about the company’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Ginkgo Bioworks (DNA) disclose?

The filing discloses that an insider intends to sell 2,200 Class A shares of Ginkgo Bioworks on the NYSE through Fidelity Brokerage Services, with an aggregate market value of $20,988.00.

How many Ginkgo Bioworks (DNA) shares are outstanding in this Form 144?

The Form 144 states that there are 48,523,595 Class A shares of Ginkgo Bioworks outstanding.

Who is selling Ginkgo Bioworks (DNA) shares in this Form 144 and how were they acquired?

The seller is Austin Che, who acquired the Class A shares through restricted stock vesting from the issuer in October 2022 as compensation.

What prior sales of Ginkgo Bioworks (DNA) shares are reported in the last 3 months?

The filing lists three prior NYSE sales by Austin Che of 2,200 Class A shares each on 09/10/2025, 10/08/2025, and 11/12/2025, with gross proceeds of $23,716.00, $33,462.00, and $18,700.00, respectively.

What representation does the seller make in the Ginkgo Bioworks (DNA) Form 144?

The seller represents that they do not know any material adverse information about Ginkgo Bioworks’ current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned Ginkgo Bioworks (DNA) share sale?

The planned sale of 2,200 Class A shares will be handled by Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/10/2025 - 11:09 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001882820
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ginkgo Bioworks Holdings, Inc.
SEC File Number	001-40097
Address of Issuer	27 DRYDOCK AVENUE 8TH FLOOR BOSTON MASSACHUSETTS 02210
Phone	(877) 442-5362
Name of Person for Whose Account the Securities are To Be Sold	Che Austin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2200	20988.00	48523595	12/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/18/2022	Restricted Stock Vesting	Issuer			195	10/18/2022	Compensation
Class A	10/19/2022	Restricted Stock Vesting	Issuer			2005	10/19/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	09/10/2025	2200	23716.00
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	10/08/2025	2200	33462.00
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	11/12/2025	2200	18700.00

144: Remarks and Signature

Remarks
Date of Notice	12/10/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Austin Che
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)